Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021.
Un-audited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2021. Windlas Biotech Ltd - 543329 - Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021.
Un-audited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2021. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call to discuss financial performance for quarter and half year ended September 30, 2021. Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday, The November 1, 2021
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2021 ,inter alia, to consider and approve Unaudited financial results of the Company for the quarter and half year ended September 30, 2021. Windlas Biotech Ltd - 543329 - Closure of Trading Window
Notice of the Board Meeting scheduled to be held on Monday, the November 1, 2021 and closure of Trading window Windlas Biotech Ltd - 543329 - Shareholding for the Period Ended September 30, 2021
Windlas Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Windlas Biotech Ltd - 543329 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0191719170 Name of the Signatory :- Ananta Narayan PandaDesignation :- Company Secretary and Compliance Officer Windlas Biotech Ltd - 543329 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBl (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2021. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. (One-to-one)